Insider Transactions in Q2 2024 at Anaptysbio, Inc (ANAB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2024
|
Dennis M Fenton |
SELL
Open market or private sale
|
Direct |
1,950
-50.0%
|
$44,850
$23.17 P/Share
|
|
Jun 18
2024
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
1,950
-50.0%
|
$44,850
$23.16 P/Share
|
|
Jun 15
2024
|
Hollings Renton |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+50.0%
|
-
|
|
Jun 15
2024
|
John A Orwin |
BUY
Exercise of conversion of derivative security
|
Direct |
2,035
+50.0%
|
-
|
|
Jun 15
2024
|
J. Anthony Ware |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+34.21%
|
-
|
|
Jun 15
2024
|
John P. Schmid |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+50.0%
|
-
|
|
Jun 15
2024
|
Magda Marquet |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+50.0%
|
-
|
|
Jun 15
2024
|
Dennis M Fenton |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+50.0%
|
-
|
|
Jun 15
2024
|
Rita Jain |
BUY
Exercise of conversion of derivative security
|
Direct |
4,534
+50.0%
|
-
|
|
May 22
2024
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,500
-60.88%
|
$34,500
$23.72 P/Share
|